0001140361-22-002458.txt : 20220124 0001140361-22-002458.hdr.sgml : 20220124 20220124114843 ACCESSION NUMBER: 0001140361-22-002458 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220120 FILED AS OF DATE: 20220124 DATE AS OF CHANGE: 20220124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Busch Andreas CENTRAL INDEX KEY: 0001775029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38787 FILM NUMBER: 22548098 MAIL ADDRESS: STREET 1: C/O CYCLERION THERAPEUTICS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc. CENTRAL INDEX KEY: 0001755237 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831895370 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4.xml FORM 4 X0306 4 2022-01-20 0001755237 Cyclerion Therapeutics, Inc. CYCN 0001775029 Busch Andreas C/O CYCLERION THERAPEUTICS, INC. 245 FIRST STREET, 18TH FLOOR CAMBRIDGE MA 02142 true Chief Scientific Officer Employee Stock Option (Right to Buy) 1.21 2022-01-20 4 A 0 135000 0 A 2032-01-20 Common Stock 135000 135000 D The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 20, 2022. /s/ Gary J. Simon, Attorney-in-Fact 2022-01-24